The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Can-Fite BioPharma Ltd(NYSE MKT:CANF)

Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of cancer, liver and inflammatory disease, COVID-19 and erectile dysfunction. The company's lead drug candidate CF101 (Piclidenoson), which is in Phase III clinical tri...
Can-Fite BioPharma Days Receivable Outstanding ttm (DSO)
Can-Fite BioPharma Op Cashflow Per Share ttm
Can-Fite BioPharma Free Cashflow Per Share ttm
Can-Fite BioPharma Cash Per Share ttm
Can-Fite BioPharma P/S ratio ttm
Can-Fite BioPharma (GAAP) P/E ratio ttm
Can-Fite BioPharma P/B ratio ttm
No extra charts and metrics for this ticker.